5月的港股医药圈迎来“双IPO高光时刻”:一个递表,一个挂牌。5月26日,核药龙头【先通医药】向港交所递交上市申请:今日,GLP-1新锐【派格生物】正式在港交所挂牌上市。一个押注核药,一个专攻慢病,两个赛道、两种模式,不约而同地把握住了政策暖风与募资窗口的回暖节奏。叠加近期监管层对未盈利企业上市的支持表态,医药IPO热潮似乎正在”稳中回温"。01先通医药递表港交所2025年5月26日,港交所官网...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.